 | • レポートコード：D0804-00703 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗毒血清の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗毒血清の種類別市場規模（人間、動物）、用途別市場規模（一価、多価）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Serum、MicroPharm、Summerland Serums (AU)、Flynn Pharma、Haffkine Bio Pharmaceutical、SAVP、CSL (AU) ・地域別グローバル市場分析 2015年-2020年 ・抗毒血清の北米市場（アメリカ、カナダ、メキシコ） ・抗毒血清のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗毒血清のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗毒血清の南米市場（ブラジル、アルゼンチン） ・抗毒血清の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：人間、動物 ・用途別分析：一価、多価 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antivenom Serum market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Antivenom Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antivenom Serum market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antivenom Serum market has been segmented into
Humans
Animals
By Application, Antivenom Serum has been segmented into:
Monovalent
Polyvalent
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antivenom Serum market presented in the report. This section sheds light on the sales growth of different regional and country-level Antivenom Serum markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antivenom Serum market.
The report offers in-depth assessment of the growth and other aspects of the Antivenom Serum market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antivenom Serum Market Share Analysis
Antivenom Serum competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antivenom Serum sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antivenom Serum sales, revenue and market share for each player covered in this report.
The major players covered in Antivenom Serum are:
Merck
Serum
MicroPharm
Summerland Serums (AU)
Flynn Pharma
Haffkine Bio Pharmaceutical
SAVP
CSL (AU)
Among other players domestic and global, Antivenom Serum market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antivenom Serum product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antivenom Serum, with price, sales, revenue and global market share of Antivenom Serum in 2018 and 2019.
Chapter 3, the Antivenom Serum competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivenom Serum breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antivenom Serum market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antivenom Serum sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antivenom Serum Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antivenom Serum Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Humans
1.2.3 Animals
1.3 Market Analysis by Application
1.3.1 Overview: Global Antivenom Serum Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Monovalent
1.3.3 Polyvalent
1.4 Overview of Global Antivenom Serum Market
1.4.1 Global Antivenom Serum Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Serum
2.2.1 Serum Details
2.2.2 Serum Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Serum SWOT Analysis
2.2.4 Serum Product and Services
2.2.5 Serum Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 MicroPharm
2.3.1 MicroPharm Details
2.3.2 MicroPharm Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 MicroPharm SWOT Analysis
2.3.4 MicroPharm Product and Services
2.3.5 MicroPharm Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Summerland Serums (AU)
2.4.1 Summerland Serums (AU) Details
2.4.2 Summerland Serums (AU) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Summerland Serums (AU) SWOT Analysis
2.4.4 Summerland Serums (AU) Product and Services
2.4.5 Summerland Serums (AU) Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Flynn Pharma
2.5.1 Flynn Pharma Details
2.5.2 Flynn Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Flynn Pharma SWOT Analysis
2.5.4 Flynn Pharma Product and Services
2.5.5 Flynn Pharma Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Haffkine Bio Pharmaceutical
2.6.1 Haffkine Bio Pharmaceutical Details
2.6.2 Haffkine Bio Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Haffkine Bio Pharmaceutical SWOT Analysis
2.6.4 Haffkine Bio Pharmaceutical Product and Services
2.6.5 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 SAVP
2.7.1 SAVP Details
2.7.2 SAVP Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SAVP SWOT Analysis
2.7.4 SAVP Product and Services
2.7.5 SAVP Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CSL (AU)
2.8.1 CSL (AU) Details
2.8.2 CSL (AU) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CSL (AU) SWOT Analysis
2.8.4 CSL (AU) Product and Services
2.8.5 CSL (AU) Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antivenom Serum Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antivenom Serum Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antivenom Serum Manufacturer Market Share in 2019
3.3.2 Top 6 Antivenom Serum Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antivenom Serum Sales, Revenue and Market Share by Regions
4.1.1 Global Antivenom Serum Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antivenom Serum Revenue and Market Share by Regions (2015-2020)
4.2 North America Antivenom Serum Sales and Growth Rate (2015-2020)
4.3 Europe Antivenom Serum Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antivenom Serum Sales and Growth Rate (2015-2020)
4.5 South America Antivenom Serum Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antivenom Serum Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antivenom Serum Sales, Revenue and Market Share by Country
5.1.1 North America Antivenom Serum Sales and Market Share by Country (2015-2020)
5.1.2 North America Antivenom Serum Revenue and Market Share by Country (2015-2020)
5.2 United States Antivenom Serum Sales and Growth Rate (2015-2020)
5.3 Canada Antivenom Serum Sales and Growth Rate (2015-2020)
5.4 Mexico Antivenom Serum Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antivenom Serum Sales, Revenue and Market Share by Country
6.1.1 Europe Antivenom Serum Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antivenom Serum Revenue and Market Share by Country (2015-2020)
6.2 Germany Antivenom Serum Sales and Growth Rate (2015-2020)
6.3 UK Antivenom Serum Sales and Growth Rate (2015-2020)
6.4 France Antivenom Serum Sales and Growth Rate (2015-2020)
6.5 Russia Antivenom Serum Sales and Growth Rate (2015-2020)
6.6 Italy Antivenom Serum Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antivenom Serum Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antivenom Serum Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antivenom Serum Revenue and Market Share by Regions (2015-2020)
7.2 China Antivenom Serum Sales and Growth Rate (2015-2020)
7.3 Japan Antivenom Serum Sales and Growth Rate (2015-2020)
7.4 Korea Antivenom Serum Sales and Growth Rate (2015-2020)
7.5 India Antivenom Serum Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antivenom Serum Sales and Growth Rate (2015-2020)
7.7 Australia Antivenom Serum Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antivenom Serum Sales, Revenue and Market Share by Country
8.1.1 South America Antivenom Serum Sales and Market Share by Country (2015-2020)
8.1.2 South America Antivenom Serum Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antivenom Serum Sales and Growth Rate (2015-2020)
8.3 Argentina Antivenom Serum Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antivenom Serum Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antivenom Serum Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antivenom Serum Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antivenom Serum Sales and Growth Rate (2015-2020)
9.3 Turkey Antivenom Serum Sales and Growth Rate (2015-2020)
9.4 Egypt Antivenom Serum Sales and Growth Rate (2015-2020)
9.5 South Africa Antivenom Serum Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antivenom Serum Sales and Market Share by Type (2015-2020)
10.2 Global Antivenom Serum Revenue and Market Share by Type (2015-2020)
10.3 Global Antivenom Serum Price by Type (2015-2020)
11 Global Antivenom Serum Market Segment by Application
11.1 Global Antivenom Serum Sales Market Share by Application (2015-2020)
11.2 Global Antivenom Serum Revenue Market Share by Application (2015-2020)
11.3 Global Antivenom Serum Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antivenom Serum Sales, Revenue and Growth Rate (2021-2025)
12.2 Antivenom Serum Market Forecast by Regions (2021-2025)
12.2.1 North America Antivenom Serum Market Forecast (2021-2025)
12.2.2 Europe Antivenom Serum Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antivenom Serum Market Forecast (2021-2025)
12.2.4 South America Antivenom Serum Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antivenom Serum Market Forecast (2021-2025)
12.3 Antivenom Serum Market Forecast by Type (2021-2025)
12.3.1 Global Antivenom Serum Sales Forecast by Type (2021-2025)
12.3.2 Global Antivenom Serum Market Share Forecast by Type (2021-2025)
12.4 Antivenom Serum Market Forecast by Application (2021-2025)
12.4.1 Global Antivenom Serum Sales Forecast by Application (2021-2025)
12.4.2 Global Antivenom Serum Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antivenom Serum Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antivenom Serum by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antivenom Serum Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Antivenom Serum Major Business
Table 9. Merck Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 10. Merck SWOT Analysis
Table 11. Merck Antivenom Serum Product and Services
Table 12. Merck Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Serum Basic Information, Manufacturing Base and Competitors
Table 14. Serum Antivenom Serum Major Business
Table 15. Serum Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 16. Serum SWOT Analysis
Table 17. Serum Antivenom Serum Product and Services
Table 18. Serum Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 20. MicroPharm Antivenom Serum Major Business
Table 21. MicroPharm Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 22. MicroPharm SWOT Analysis
Table 23. MicroPharm Antivenom Serum Product and Services
Table 24. MicroPharm Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Summerland Serums (AU) Basic Information, Manufacturing Base and Competitors
Table 26. Summerland Serums (AU) Antivenom Serum Major Business
Table 27. Summerland Serums (AU) Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 28. Summerland Serums (AU) SWOT Analysis
Table 29. Summerland Serums (AU) Antivenom Serum Product and Services
Table 30. Summerland Serums (AU) Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Flynn Pharma Antivenom Serum Major Business
Table 33. Flynn Pharma Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 34. Flynn Pharma SWOT Analysis
Table 35. Flynn Pharma Antivenom Serum Product and Services
Table 36. Flynn Pharma Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Haffkine Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Haffkine Bio Pharmaceutical Antivenom Serum Major Business
Table 39. Haffkine Bio Pharmaceutical Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 40. Haffkine Bio Pharmaceutical SWOT Analysis
Table 41. Haffkine Bio Pharmaceutical Antivenom Serum Product and Services
Table 42. Haffkine Bio Pharmaceutical Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. SAVP Basic Information, Manufacturing Base and Competitors
Table 44. SAVP Antivenom Serum Major Business
Table 45. SAVP Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 46. SAVP SWOT Analysis
Table 47. SAVP Antivenom Serum Product and Services
Table 48. SAVP Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. CSL (AU) Basic Information, Manufacturing Base and Competitors
Table 50. CSL (AU) Antivenom Serum Major Business
Table 51. CSL (AU) Antivenom Serum Total Revenue (USD Million) (2018-2019)
Table 52. CSL (AU) SWOT Analysis
Table 53. CSL (AU) Antivenom Serum Product and Services
Table 54. CSL (AU) Antivenom Serum Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Antivenom Serum Sales by Manufacturer (2018-2019) (K Doses)
Table 56. Global Antivenom Serum Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Antivenom Serum Sales by Regions (2015-2020) (K Doses)
Table 58. Global Antivenom Serum Sales Market Share by Regions (2015-2020)
Table 59. Global Antivenom Serum Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Antivenom Serum Sales by Countries (2015-2020) (K Doses)
Table 61. North America Antivenom Serum Sales Market Share by Countries (2015-2020)
Table 62. North America Antivenom Serum Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Antivenom Serum Revenue Market Share by Countries (2015-2020)
Table 64. Europe Antivenom Serum Sales by Countries (2015-2020) (K Doses)
Table 65. Europe Antivenom Serum Sales Market Share by Countries (2015-2020)
Table 66. Europe Antivenom Serum Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Antivenom Serum Sales by Regions (2015-2020) (K Doses)
Table 68. Asia-Pacific Antivenom Serum Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Antivenom Serum Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Antivenom Serum Sales by Countries (2015-2020) (K Doses)
Table 71. South America Antivenom Serum Sales Market Share by Countries (2015-2020)
Table 72. South America Antivenom Serum Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Antivenom Serum Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Antivenom Serum Sales by Countries (2015-2020) (K Doses)
Table 75. Middle East & Africa Antivenom Serum Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Antivenom Serum Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Antivenom Serum Revenue Market Share by Countries (2015-2020)
Table 78. Global Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 79. Global Antivenom Serum Sales Share by Type (2015-2020)
Table 80. Global Antivenom Serum Revenue by Type (2015-2020) (USD Million)
Table 81. Global Antivenom Serum Revenue Share by Type (2015-2020)
Table 82. Global Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 83. Global Antivenom Serum Sales Share by Application (2015-2020)
Table 84. Global Antivenom Serum Sales Forecast by Regions (2021-2025) (K Doses)
Table 85. Global Antivenom Serum Market Share Forecast by Regions (2021-2025)
Table 86. Global Antivenom Serum Sales Forecast by Type (2021-2025) (K Doses)
Table 87. Global Antivenom Serum Market Share Forecast by Type (2021-2025)
Table 88. Global Antivenom Serum Sales Forecast by Application (2021-2025)
Table 89. Global Antivenom Serum Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antivenom Serum Picture
Figure 2. Global Sales Market Share of Antivenom Serum by Type in 2019
Figure 3. Humans Picture
Figure 4. Animals Picture
Figure 5. Antivenom Serum Sales Market Share by Application in 2018
Figure 6. Monovalent Picture
Figure 7. Polyvalent Picture
Figure 8. Global Antivenom Serum Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Antivenom Serum Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Antivenom Serum Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Antivenom Serum Sales Market Share by Manufacturer in 2019
Figure 29. Global Antivenom Serum Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Antivenom Serum Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Antivenom Serum Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 34. Global Antivenom Serum Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Antivenom Serum Revenue Market Share by Regions (2015-2020)
Figure 36. Global Antivenom Serum Revenue Market Share by Regions in 2018
Figure 37. North America Antivenom Serum Sales and Growth Rate (2015-2020)
Figure 38. Europe Antivenom Serum Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Antivenom Serum Sales and Growth Rate (2015-2020)
Figure 40. South America Antivenom Serum Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Antivenom Serum Sales and Growth Rate (2015-2020)
Figure 42. North America Antivenom Serum Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Antivenom Serum Sales Market Share by Countries (2015-2020)
Figure 44. North America Antivenom Serum Sales Market Share by Countries in 2018
Figure 45. North America Antivenom Serum Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Antivenom Serum Revenue Market Share by Countries in 2018
Figure 47. United States Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 48. Canada Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Mexico Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Europe Antivenom Serum Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Antivenom Serum Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Antivenom Serum Revenue Market Share by Countries in 2019
Figure 53. Germany Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. UK Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. France Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Russia Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Asia-Pacific Antivenom Serum Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Antivenom Serum Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Antivenom Serum Revenue Market Share by Regions 2019
Figure 61. China Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Korea Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. India Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Southeast Asia Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. South America Antivenom Serum Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Antivenom Serum Sales Market Share by Countries in 2019
Figure 68. South America Antivenom Serum Revenue Market Share by Countries in 2019
Figure 69. Brazil Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Middle East and Africa Antivenom Serum Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Antivenom Serum Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Antivenom Serum Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Antivenom Serum Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Egypt Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Turkey Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. South Africa Antivenom Serum Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Global Antivenom Serum Sales and Growth Rate (2021-2025) (K Doses)
Figure 80. Global Antivenom Serum Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Antivenom Serum Market Forecast (2021-2025) (K Doses)
Figure 82. Europe Sales Antivenom Serum Market Forecast (2021-2025) (K Doses)
Figure 83. Asia-Pacific Sales Antivenom Serum Market Forecast (2021-2025) (K Doses)
Figure 84. South America Sales Antivenom Serum Market Forecast (2021-2025) (K Doses)
Figure 85. Middle East & Africa Sales Antivenom Serum Market Forecast (2021-2025) (K Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
反毒素の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Venom market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 991.8 million by 2025, from USD 898.9 million in 2019. The Anti-Venom market report pr…- 反毒素の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Venom market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 991.8 million by 2025, from USD 898.9 million in 2019. The Anti-Venom market report pr…
- 血清抗体精製キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Serum Antibody Purification Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Serum Antibod…
- 血清抗体精製キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Serum Antibody Purification Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Serum Antibod…
- 乾燥ウシ血清アルブミンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dry Bovine Serum Albumin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dry Bovine Serum Alb…